19280sek
0,5 %
Date:2025-05-19Time:17:29:40Latest report:Q1-2025List:Mid CapTicker:CEVI
Market Cap:4 599 msekEnterprise Value:4 439 msekNet Sales:747,9 msekEarnings:152,1 msekEmployees:0ISIN:SE0000683484

Ratios

10-year key figure history for CellaVision turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for CellaVision with index and moving average MA50 and MA200.

Stockprice:192,80
MA50:172,64
MA200:221,68
Price/MA200:-13,0 %
RSI (14):62,6
Price/MA50:11,7 %

Description

CellaVision operates in the medical technology industry and focuses on the development and manufacture of systems for digital blood analysis. The company focuses on digital cell morphology and offers innovations for analyzers, instruments, reagents and software used in hematology laboratories. The company's products are aimed at healthcare institutions and laboratories worldwide. CellaVision was founded in 1994 and is headquartered in Lund, Sweden.

Medical Equipment